Fig. 2
From: Simplified dosimetry for kidneys and tumors in 177Lu-labeled peptide receptor radionuclide therapy
Normalized absorbed doses to kidneys (a) and tumors (b) calculated with administered activities and dose-per-activity values from the first treatment cycle. Absorbed doses are normalized to the “true” absorbed doses, n corresponds to number of data points included in the calculation for the corresponding treatment cycle. “All” refers to the total absorbed dose from all treatment cycles. A value of 17.5 for cycle 4 was cropped from Fig. 2b